相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
Apostolia-Maria Tsimberidou et al.
CLINICAL CANCER RESEARCH (2012)
Translating genomic information into clinical medicine: Lung cancer as a paradigm
Mia A. Levy et al.
GENOME RESEARCH (2012)
Cancer Genomics: Technology, Discovery, and Translation
Ben Tran et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized Phase II Trial Designs With Biomarkers
Boris Freidlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: The case of the Institut Gustave Roussy
Monica Arnedos et al.
MOLECULAR ONCOLOGY (2012)
Assuring the quality of next-generation sequencing in clinical laboratory practice
Amy S. Gargis et al.
NATURE BIOTECHNOLOGY (2012)
Targeted therapies: how personal should we go?
Miriam Martini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Tumour molecular profiling for deciding therapy-the French initiative
Frederique Nowak et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Genome Sequencing Identifies a Basis for Everolimus Sensitivity
Gopa Iyer et al.
SCIENCE (2012)
Clinical trials for predictive medicine
Richard Simon
STATISTICS IN MEDICINE (2012)
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial
Christophe Le Tourneau et al.
TARGETED ONCOLOGY (2012)
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
L. V. Sequist et al.
ANNALS OF ONCOLOGY (2011)
Adaptive Clinical Trial Designs for Simultaneous Testing of Matched Diagnostics and Therapeutics
Howard I. Scher et al.
CLINICAL CANCER RESEARCH (2011)
Outcome-Adaptive Randomization: Is It Useful?
Edward L. Korn et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
Alice T. Shaw et al.
LANCET ONCOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
Sameek Roychowdhury et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim et al.
CANCER DISCOVERY (2011)
Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
A. D. Barker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
Marc Ladanyi et al.
MODERN PATHOLOGY (2008)
Biomarker-adaptive threshold design: A procedure for evaluating treatment with possible biomarker-defined subset effect
Wenyu Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Target practice: oncology drug development in the era of genomic medicine
Richard L. Schilsky
CLINICAL TRIALS (2007)
An adaptive Simon Two-Stage Design for phase 2 studies of targeted therapies
Cheryl L. Jones et al.
CONTEMPORARY CLINICAL TRIALS (2007)
Clinical trial design for microarray predictive marker discovery and assessment
L Pusztai et al.
ANNALS OF ONCOLOGY (2004)
分享论文
